business π Symbiotec IPO debuts flat despite high GMP hopes π
Symbiotec Pharmalab had a muted debut on Dalal Street on Tuesday, September 1, which was below grey market expectations. The company, based in Madhya Pradesh, saw its stock open at βΉ978.20 on the BSE and list at βΉ988 on the NSE. The βΉ1,757-crore IPO was subscribed 71.26 times, with an IPO price band set between βΉ933-988. The company plans to use fresh issue proceeds for debt repayment and general corporate purposes moving forward. Symbiotec expects investments in complex injectables and fermentation CDMO to be major growth drivers in the coming years.